Market Cap
₹120 Cr.
P/E
0.00
About
Lasa Supergenerics Limited was incorporated in 2016 having its registered office in Ratnagiri, Maharashtra. The company is primarily engaged in the business of manufacturing API bulk drugs products.
Lasa Supergenerics Limited was incorporated in 2016 having its registered office in Ratnagiri,… Read more
Low
19
52W Range
High
41
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

4 Yes

Positive for this company

2 Neutral

Neutral for this company

10 No

Negative for this company

1 No Data

Insufficient data to analyse

ROE
Latest
-32.65%
3yr Average
-7.23%
5yr Average
-6.11%
Net Profit Margin
Latest
-29.81%
3yr Average
-7.48%
5yr Average
-5.47%
ROCE
Latest
-15.0%
3yr Average
1.65%
5yr Average
1.63%
Debt to Equity
Latest
0.18
3yr Average
0.14
5yr Average
0.32
Revenue mix

Segment Break-Up

Location Wise Break-Up

Peer Comparison
FAQs on Lasa Supergenerics Ltd. Business

Lasa Supergenerics Limited, established in 2016 in Ratnagiri, Maharashtra, specializes in the manufacturing of API bulk drugs products.

Lasa Supergenerics major competitors are Everest Organics, Mangalam Drugs&Org., Tyche Inds, Bal Pharma, Smruthi Organics, SMS Lifesciences, Nectar Lifesciences.
Market Cap of Lasa Supergenerics is ₹120 Crs.
While the median market cap of its peers are ₹188 Crs.

Lasa Supergenerics seems to be financially stable compared to its peers.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate peers.

Company Filing
2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Jun Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Investor Presentation Jun Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call Jun Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Jun Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Discussions & Analysis
Lasa Supergenerics Ltd.